Saudi - Delayed Quote SAR

Canadian General Medical Center Complex Company (9518.SR)

Compare
6.16
0.00
(0.00%)
At close: 3:19:44 PM GMT+3
Loading Chart for 9518.SR
  • Previous Close 6.16
  • Open 6.36
  • Bid 6.16 x --
  • Ask 6.17 x --
  • Day's Range 6.07 - 6.36
  • 52 Week Range 5.36 - 8.37
  • Volume 86,589
  • Avg. Volume 136,567
  • Market Cap (intraday) 485.1M
  • Beta (5Y Monthly) 0.52
  • PE Ratio (TTM) 44.00
  • EPS (TTM) 0.14
  • Earnings Date --
  • Forward Dividend & Yield 0.05 (0.81%)
  • Ex-Dividend Date May 12, 2025
  • 1y Target Est --

Canadian General Medical Center Complex Company manages hospitals and health centers in the Kingdom of Saudi Arabia. Its services include pediatric clinic, internal medicine, eye clinic, ear, nose and throat clinic, general medicine, emergency department, radiology department, and laboratory, as well as provides medical services to oil and gas well drilling companies. The company also trades in hospital tools and equipment, and ambulances. The company was incorporated in 2008 and is based in Dammam, the Kingdom of Saudi Arabia.

sa.canadian-mc.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 9518.SR

View More

Performance Overview: 9518.SR

Trailing total returns as of 4/21/2025, which may include dividends or other distributions. Benchmark is Tadawul All Shares Index (^TASI.SR) .

YTD Return

9518.SR
12.62%
Tadawul All Shares Index (^TASI.SR)
4.05%

1-Year Return

9518.SR
11.87%
Tadawul All Shares Index (^TASI.SR)
7.75%

3-Year Return

9518.SR
2.55%
Tadawul All Shares Index (^TASI.SR)
14.67%

5-Year Return

9518.SR
40.19%
Tadawul All Shares Index (^TASI.SR)
77.76%

Compare To: 9518.SR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 9518.SR

View More

Valuation Measures

Annual
As of 4/20/2025
  • Market Cap

    474.32M

  • Enterprise Value

    436.45M

  • Trailing P/E

    44.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.46

  • Price/Book (mrq)

    5.39

  • Enterprise Value/Revenue

    4.10

  • Enterprise Value/EBITDA

    26.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.42%

  • Return on Assets (ttm)

    6.10%

  • Return on Equity (ttm)

    12.39%

  • Revenue (ttm)

    106.35M

  • Net Income Avi to Common (ttm)

    11.08M

  • Diluted EPS (ttm)

    0.14

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    45.48M

  • Total Debt/Equity (mrq)

    8.64%

  • Levered Free Cash Flow (ttm)

    3.07M

Research Analysis: 9518.SR

View More

Company Insights: 9518.SR

Research Reports: 9518.SR

View More

People Also Watch